The Solventum spin-off will help 3M prepare for legal settlements related to defective earplugs and water supply damages. 3M is risky due to potential future additional legal battles. 3M is a slow ...
Morgan Stanley raised the firm’s price target on Solventum (SOLV) to $73 from $60 and keeps an Equal Weight rating on the shares. Solventum, which “had a clean 3Q print,” seems to be navigating a ...
Solventum, the 3M healthcare spinoff, eliminated 800 positions as part of a restructuring strategy to help fuel growth. CEO Bryan Hanson, in an investor day presentation last week, said the ...
It’s been almost a year since Solventum spun off as a separate business from 3M. Now, Solventum is orchestrating a spinoff of its own. On Tuesday, Solventum announced that it has lined up a deal to ...
3M has finished carving out its healthcare business, formally establishing Solventum as an independent, St. Paul, Minnesota-based manufacturer of a medtech catalog that brought in $8.2 billion in 2023 ...
7 analysts have shared their evaluations of Solventum (NYSE:SOLV) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...
Hosted on MSN
Solventum’s (NYSE:SOLV) Q3: Beats On Revenue
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q3 CY2025 results , but sales were flat year on year at $2.10 billion. Its non-GAAP profit of $1.50 per share was 4.7% above analysts’ ...
On Thursday, Solventum (NYSE:SOLV) hosted its 2025 Investor Day, during which it outlined its strategic priorities, its business segments, and its long-range plan (LRP) to drive growth and value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results